{"gene":"GNA15","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1996,"finding":"Gna15 is tandemly duplicated with Gna11 on mouse chromosome 10 in a head-to-tail arrangement; the coding sequence spans seven exons with conserved intron positions relative to Gna11, consistent with origin by tandem duplication from a common progenitor. Expression of Gna15 is restricted to hematopoietic cells, unlike the ubiquitously expressed Gna11.","method":"Genomic sequencing, gene structure characterization, expression analysis (Northern blot/tissue panel)","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct genomic characterization with expression profiling, single lab, multiple methods","pmids":["8838318"],"is_preprint":false},{"year":2002,"finding":"The Gna15 gene is located in tandem just upstream of the s1p4/Edg6 GPCR gene on mouse chromosome 10 (and human chromosome 19p13.3), and Northern blot analysis showed similar tissue distributions of the two transcripts, suggesting co-regulation and potential in vivo coupling between Gα15 and S1P4.","method":"Genomic analysis, Northern blot","journal":"FEBS letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — genomic co-localization and expression correlation only; functional coupling is proposed but not experimentally confirmed","pmids":["12401211"],"is_preprint":false},{"year":2015,"finding":"In the small intestinal neuroendocrine tumor cell line KRJ-I, Gα15 (GNA15) couples to the β1 adrenergic receptor and modulates proliferative signaling through this GPCR; knockdown of GNA15 inhibited proliferation, activated apoptosis, and altered ERK, NFκB, and Akt pathway signaling.","method":"siRNA knockdown, immunoprecipitation (coupling assay), proliferation/apoptosis assays, Western blot","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal immunoprecipitation demonstrating GPCR coupling combined with loss-of-function phenotype and pathway readout, single lab","pmids":["25701539"],"is_preprint":false},{"year":2024,"finding":"GNA15 binds to BTK and activates the MAPK signaling pathway (phosphorylation of ERK, JNK, and p38) in thyroid carcinoma cells; BTK knockdown blocked MAPK activation and reduced malignant cell behaviors, effects that were rescued by GNA15 overexpression.","method":"Co-immunoprecipitation/binding assay, BTK knockdown, rescue assay, Western blot (p-ERK, p-JNK, p-p38), viability/migration/invasion assays","journal":"Histology and histopathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding demonstrated and epistasis established by knockdown-rescue, single lab, multiple orthogonal assays","pmids":["38333922"],"is_preprint":false},{"year":2024,"finding":"CD312 (a GPCR) interacts directly with GNA15 at its transmembrane intracellular segment; CD312 overexpression promotes leukemia cell proliferation through phosphorylation of ERK, JNK, and p38 via GNA15, and GNA15 knockdown abrogates this proliferative effect in a co-culture system.","method":"Affinity/binding assay (transmembrane interaction), BrdU proliferation assay, GNA15 knockdown, co-culture system, Western blot","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction demonstrated and GNA15 epistasis confirmed by knockdown in co-culture, single lab","pmids":["39656442"],"is_preprint":false},{"year":2025,"finding":"GNA15 promotes fatty acid oxidation (FAO) in B-ALL leukemia cells by upregulating AMPK phosphorylation, leading to increased expression of FAO enzymes CPT1, CPT2, and CD36; inhibition of FAO with etomoxir partially reverses GNA15-driven drug resistance.","method":"Metabolomics, Western blot (p-AMPK, CPT1, CPT2, CD36), FAO inhibition (etomoxir), overexpression/knockdown functional assays","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — metabolomics plus pathway rescue with FAO inhibitor, single lab, multiple orthogonal methods","pmids":["39812998"],"is_preprint":false},{"year":2023,"finding":"miR-211-5p suppresses GNA15 expression in melanoma cells, and this suppression mediates transfer of metastatic competency by inhibiting pyroptosis and augmenting glycolysis within recipient cells, as well as modifying immune function of the tumor microenvironment.","method":"miRNA target validation (computational + wet-lab), gain/loss-of-function in melanoma cell lines, glycolysis and pyroptosis functional assays, exosome transfer experiments","journal":"Pharmacological research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mechanistic claims rely heavily on computational discovery with limited direct validation of GNA15-specific mechanism","pmids":["36642112"],"is_preprint":false}],"current_model":"GNA15 encodes Gα15, a hematopoietic-restricted Gq-class G protein alpha subunit that couples promiscuously to GPCRs (including β1 adrenergic receptor and CD312), transducing signals through the MAPK (ERK/JNK/p38), NFκB, and Akt pathways, and in cancer contexts activates AMPK-driven fatty acid oxidation to confer drug resistance and promotes malignant cell proliferation, survival, and migration."},"narrative":{"mechanistic_narrative":"GNA15 encodes a hematopoietic-restricted Gq-class G protein alpha subunit that transduces GPCR signals into proliferative and survival programs across normal hematopoietic and malignant cells [PMID:8838318, PMID:25701539]. It arose by tandem duplication alongside Gna11 but, unlike the ubiquitously expressed Gna11, its expression is confined to hematopoietic lineages [PMID:8838318]. Gα15 couples promiscuously to diverse GPCRs—including the β1 adrenergic receptor in neuroendocrine tumor cells, where its loss suppresses proliferation, triggers apoptosis, and dampens ERK, NFκB, and Akt signaling [PMID:25701539], and the adhesion GPCR CD312, which engages Gα15 at its transmembrane intracellular segment to drive leukemia cell proliferation via ERK, JNK, and p38 phosphorylation [PMID:39656442]. In thyroid carcinoma, Gα15 binds BTK to activate the same MAPK cascade, with BTK acting as a required intermediate for malignant proliferation, migration, and invasion [PMID:38333922]. Beyond canonical MAPK output, Gα15 reprograms metabolism in B-ALL leukemia cells by upregulating AMPK phosphorylation and the fatty acid oxidation machinery (CPT1, CPT2, CD36), conferring drug resistance reversible by FAO inhibition [PMID:39812998]. Collectively these findings position Gα15 as a node linking GPCR engagement to MAPK-driven growth and metabolic adaptation in cancer.","teleology":[{"year":1996,"claim":"Established GNA15 as a distinct Gq-class alpha subunit gene whose expression—unlike its paralog Gna11—is restricted to hematopoietic cells, defining the lineage context for its later signaling roles.","evidence":"Genomic sequencing and gene-structure characterization with Northern blot tissue profiling in mouse","pmids":["8838318"],"confidence":"Medium","gaps":["No biochemical demonstration of GPCR coupling or downstream effector at this stage","Functional role of the hematopoietic restriction untested"]},{"year":2002,"claim":"Raised the possibility of in vivo coupling between Gα15 and the S1P4/Edg6 receptor based on tandem genomic arrangement and co-expression, addressing which GPCRs Gα15 might serve.","evidence":"Genomic co-localization analysis and Northern blot expression correlation in mouse and human","pmids":["12401211"],"confidence":"Low","gaps":["Functional coupling between Gα15 and S1P4 proposed from co-expression only, not experimentally confirmed","No signaling readout"]},{"year":2015,"claim":"Demonstrated direct functional GPCR coupling, showing Gα15 links the β1 adrenergic receptor to proliferative MAPK/NFκB/Akt signaling in neuroendocrine tumor cells.","evidence":"Reciprocal immunoprecipitation coupling assay plus siRNA knockdown with proliferation/apoptosis and pathway Western blots in KRJ-I cells","pmids":["25701539"],"confidence":"Medium","gaps":["Single cell line context","Direct GTP-loading/effector activation by Gα15 not measured","Receptor specificity beyond β1AR not mapped"]},{"year":2024,"claim":"Defined a BTK-dependent route from Gα15 to the full MAPK cascade (ERK/JNK/p38) driving malignant behavior, addressing how Gα15 transmits signal to the kinase module.","evidence":"Co-immunoprecipitation, BTK knockdown with GNA15-overexpression rescue, and viability/migration/invasion assays in thyroid carcinoma cells","pmids":["38333922"],"confidence":"Medium","gaps":["Mechanism of Gα15–BTK binding (direct vs indirect) not resolved","Single lab, single tumor type"]},{"year":2024,"claim":"Identified CD312 as a GPCR that engages Gα15 at its transmembrane intracellular segment to drive leukemia proliferation, extending the receptor repertoire feeding into Gα15-MAPK signaling.","evidence":"Transmembrane interaction binding assay, BrdU proliferation, GNA15 knockdown in a co-culture system with MAPK Western blots","pmids":["39656442"],"confidence":"Medium","gaps":["Structural basis of the transmembrane interaction not defined","Co-culture system may not reflect cell-autonomous signaling"]},{"year":2025,"claim":"Connected Gα15 to metabolic reprogramming, showing it activates AMPK-driven fatty acid oxidation to confer drug resistance—revealing a non-MAPK output relevant to therapy.","evidence":"Metabolomics, p-AMPK/CPT1/CPT2/CD36 Western blots, FAO inhibition with etomoxir, and overexpression/knockdown functional assays in B-ALL cells","pmids":["39812998"],"confidence":"Medium","gaps":["How GPCR/Gα15 signaling links mechanistically to AMPK activation unresolved","FAO inhibition only partially reverses resistance, implying additional effectors"]},{"year":2023,"claim":"Placed GNA15 under miR-211-5p control as a node influencing pyroptosis, glycolysis, and tumor-microenvironment immune function in melanoma metastasis.","evidence":"miRNA target validation, gain/loss-of-function, glycolysis/pyroptosis assays, and exosome transfer in melanoma cell lines","pmids":["36642112"],"confidence":"Low","gaps":["GNA15-specific mechanism relies heavily on computational prediction with limited direct validation","Causal chain from GNA15 to pyroptosis/glycolysis not dissected"]},{"year":null,"claim":"It remains unknown how Gα15's promiscuous receptor coupling is mechanistically reconciled with both MAPK activation and AMPK-driven metabolic rewiring, and whether a single effector logic operates across hematopoietic and solid-tumor contexts.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural or biochemical reconstitution of Gα15 effector selectivity","Direct effector(s) bridging Gα15 to AMPK not identified","In vivo physiological role beyond cancer models uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,3,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,4]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5]}],"complexes":[],"partners":["ADRB1","BTK","ADGRE5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P30679","full_name":"Guanine nucleotide-binding protein subunit alpha-15","aliases":["Epididymis tissue protein Li 17E","Guanine nucleotide-binding protein subunit alpha-16","G alpha-16","G-protein subunit alpha-16"],"length_aa":374,"mass_kda":43.5,"function":"Member of the G-protein alpha subunit family that plays a crucial role in intracellular signaling. Functions as a molecular switch, transducing signals from G protein-coupled receptors (GPCRs) to downstream effectors. In collaboration with the adapter protein TTC1, promotes HRAS activation and ERK1/2 phosphorylation independently of phospholipase Cbeta signaling (PubMed:12748287, PubMed:20639119). Also initiates EMR2-mediated signaling, leading to activation of Akt, MAPK, and NF-kappa-B, which in turn drives macrophage differentiation and inflammatory responses (PubMed:28421075)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P30679/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNA15","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNA15","total_profiled":1310},"omim":[{"mim_id":"621535","title":"SPINOCEREBELLAR ATAXIA 52; SCA52","url":"https://www.omim.org/entry/621535"},{"mim_id":"603751","title":"SPHINGOSINE-1-PHOSPHATE RECEPTOR 4; S1PR4","url":"https://www.omim.org/entry/603751"},{"mim_id":"179490","title":"RAS-ASSOCIATED PROTEIN RAB3A; RAB3A","url":"https://www.omim.org/entry/179490"},{"mim_id":"139314","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-15; GNA15","url":"https://www.omim.org/entry/139314"},{"mim_id":"139313","title":"GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-11; GNA11","url":"https://www.omim.org/entry/139313"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":71.2},{"tissue":"esophagus","ntpm":99.4}],"url":"https://www.proteinatlas.org/search/GNA15"},"hgnc":{"alias_symbol":["GNA16"],"prev_symbol":[]},"alphafold":{"accession":"P30679","domains":[{"cath_id":"3.40.50.300","chopping":"46-69_189-327_335-363","consensus_level":"medium","plddt":94.099,"start":46,"end":363},{"cath_id":"1.10.400.10","chopping":"71-183","consensus_level":"medium","plddt":95.3235,"start":71,"end":183}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30679","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30679-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30679-F1-predicted_aligned_error_v6.png","plddt_mean":90.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNA15","jax_strain_url":"https://www.jax.org/strain/search?query=GNA15"},"sequence":{"accession":"P30679","fasta_url":"https://rest.uniprot.org/uniprotkb/P30679.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30679/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30679"}},"corpus_meta":[{"pmid":"36642112","id":"PMC_36642112","title":"Exosomal miR-211-5p regulates glucose metabolism, pyroptosis, and immune microenvironment of melanoma through GNA15.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/36642112","citation_count":34,"is_preprint":false},{"pmid":"8838318","id":"PMC_8838318","title":"Gene structure of murine Gna11 and Gna15: tandemly duplicated Gq class G protein alpha subunit genes.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8838318","citation_count":26,"is_preprint":false},{"pmid":"25701539","id":"PMC_25701539","title":"GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25701539","citation_count":17,"is_preprint":false},{"pmid":"12401211","id":"PMC_12401211","title":"Tandem genomic arrangement of a G protein (Gna15) and G protein-coupled receptor (s1p(4)/lp(C1)/Edg6) gene.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12401211","citation_count":13,"is_preprint":false},{"pmid":"39812998","id":"PMC_39812998","title":"GNA15 induces drug resistance in B cell acute lymphoblastic leukemia by promoting fatty acid oxidation via activation of the AMPK pathway.","date":"2025","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39812998","citation_count":7,"is_preprint":false},{"pmid":"38333922","id":"PMC_38333922","title":"GNA15 facilitates the malignant development of thyroid carcinoma cells via the BTK-mediated MAPK signaling pathway.","date":"2024","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/38333922","citation_count":4,"is_preprint":false},{"pmid":"39656442","id":"PMC_39656442","title":"CD312 Promotes Paediatric Acute Lymphoblastic Leukaemia Through GNA15-Mediated Non-Classical GPCR Signalling Pathway.","date":"2024","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39656442","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":5383,"output_tokens":1702,"usd":0.02084,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8553,"output_tokens":2711,"usd":0.05527,"stage2_stop_reason":"end_turn"},"total_usd":0.07611,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"Gna15 is tandemly duplicated with Gna11 on mouse chromosome 10 in a head-to-tail arrangement; the coding sequence spans seven exons with conserved intron positions relative to Gna11, consistent with origin by tandem duplication from a common progenitor. Expression of Gna15 is restricted to hematopoietic cells, unlike the ubiquitously expressed Gna11.\",\n      \"method\": \"Genomic sequencing, gene structure characterization, expression analysis (Northern blot/tissue panel)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct genomic characterization with expression profiling, single lab, multiple methods\",\n      \"pmids\": [\"8838318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The Gna15 gene is located in tandem just upstream of the s1p4/Edg6 GPCR gene on mouse chromosome 10 (and human chromosome 19p13.3), and Northern blot analysis showed similar tissue distributions of the two transcripts, suggesting co-regulation and potential in vivo coupling between Gα15 and S1P4.\",\n      \"method\": \"Genomic analysis, Northern blot\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — genomic co-localization and expression correlation only; functional coupling is proposed but not experimentally confirmed\",\n      \"pmids\": [\"12401211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In the small intestinal neuroendocrine tumor cell line KRJ-I, Gα15 (GNA15) couples to the β1 adrenergic receptor and modulates proliferative signaling through this GPCR; knockdown of GNA15 inhibited proliferation, activated apoptosis, and altered ERK, NFκB, and Akt pathway signaling.\",\n      \"method\": \"siRNA knockdown, immunoprecipitation (coupling assay), proliferation/apoptosis assays, Western blot\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal immunoprecipitation demonstrating GPCR coupling combined with loss-of-function phenotype and pathway readout, single lab\",\n      \"pmids\": [\"25701539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GNA15 binds to BTK and activates the MAPK signaling pathway (phosphorylation of ERK, JNK, and p38) in thyroid carcinoma cells; BTK knockdown blocked MAPK activation and reduced malignant cell behaviors, effects that were rescued by GNA15 overexpression.\",\n      \"method\": \"Co-immunoprecipitation/binding assay, BTK knockdown, rescue assay, Western blot (p-ERK, p-JNK, p-p38), viability/migration/invasion assays\",\n      \"journal\": \"Histology and histopathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding demonstrated and epistasis established by knockdown-rescue, single lab, multiple orthogonal assays\",\n      \"pmids\": [\"38333922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CD312 (a GPCR) interacts directly with GNA15 at its transmembrane intracellular segment; CD312 overexpression promotes leukemia cell proliferation through phosphorylation of ERK, JNK, and p38 via GNA15, and GNA15 knockdown abrogates this proliferative effect in a co-culture system.\",\n      \"method\": \"Affinity/binding assay (transmembrane interaction), BrdU proliferation assay, GNA15 knockdown, co-culture system, Western blot\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction demonstrated and GNA15 epistasis confirmed by knockdown in co-culture, single lab\",\n      \"pmids\": [\"39656442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNA15 promotes fatty acid oxidation (FAO) in B-ALL leukemia cells by upregulating AMPK phosphorylation, leading to increased expression of FAO enzymes CPT1, CPT2, and CD36; inhibition of FAO with etomoxir partially reverses GNA15-driven drug resistance.\",\n      \"method\": \"Metabolomics, Western blot (p-AMPK, CPT1, CPT2, CD36), FAO inhibition (etomoxir), overexpression/knockdown functional assays\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — metabolomics plus pathway rescue with FAO inhibitor, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"39812998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"miR-211-5p suppresses GNA15 expression in melanoma cells, and this suppression mediates transfer of metastatic competency by inhibiting pyroptosis and augmenting glycolysis within recipient cells, as well as modifying immune function of the tumor microenvironment.\",\n      \"method\": \"miRNA target validation (computational + wet-lab), gain/loss-of-function in melanoma cell lines, glycolysis and pyroptosis functional assays, exosome transfer experiments\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mechanistic claims rely heavily on computational discovery with limited direct validation of GNA15-specific mechanism\",\n      \"pmids\": [\"36642112\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNA15 encodes Gα15, a hematopoietic-restricted Gq-class G protein alpha subunit that couples promiscuously to GPCRs (including β1 adrenergic receptor and CD312), transducing signals through the MAPK (ERK/JNK/p38), NFκB, and Akt pathways, and in cancer contexts activates AMPK-driven fatty acid oxidation to confer drug resistance and promotes malignant cell proliferation, survival, and migration.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNA15 encodes a hematopoietic-restricted Gq-class G protein alpha subunit that transduces GPCR signals into proliferative and survival programs across normal hematopoietic and malignant cells [#0, #2]. It arose by tandem duplication alongside Gna11 but, unlike the ubiquitously expressed Gna11, its expression is confined to hematopoietic lineages [#0]. Gα15 couples promiscuously to diverse GPCRs—including the β1 adrenergic receptor in neuroendocrine tumor cells, where its loss suppresses proliferation, triggers apoptosis, and dampens ERK, NFκB, and Akt signaling [#2], and the adhesion GPCR CD312, which engages Gα15 at its transmembrane intracellular segment to drive leukemia cell proliferation via ERK, JNK, and p38 phosphorylation [#4]. In thyroid carcinoma, Gα15 binds BTK to activate the same MAPK cascade, with BTK acting as a required intermediate for malignant proliferation, migration, and invasion [#3]. Beyond canonical MAPK output, Gα15 reprograms metabolism in B-ALL leukemia cells by upregulating AMPK phosphorylation and the fatty acid oxidation machinery (CPT1, CPT2, CD36), conferring drug resistance reversible by FAO inhibition [#5]. Collectively these findings position Gα15 as a node linking GPCR engagement to MAPK-driven growth and metabolic adaptation in cancer.\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established GNA15 as a distinct Gq-class alpha subunit gene whose expression—unlike its paralog Gna11—is restricted to hematopoietic cells, defining the lineage context for its later signaling roles.\",\n      \"evidence\": \"Genomic sequencing and gene-structure characterization with Northern blot tissue profiling in mouse\",\n      \"pmids\": [\"8838318\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical demonstration of GPCR coupling or downstream effector at this stage\", \"Functional role of the hematopoietic restriction untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Raised the possibility of in vivo coupling between Gα15 and the S1P4/Edg6 receptor based on tandem genomic arrangement and co-expression, addressing which GPCRs Gα15 might serve.\",\n      \"evidence\": \"Genomic co-localization analysis and Northern blot expression correlation in mouse and human\",\n      \"pmids\": [\"12401211\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Functional coupling between Gα15 and S1P4 proposed from co-expression only, not experimentally confirmed\", \"No signaling readout\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated direct functional GPCR coupling, showing Gα15 links the β1 adrenergic receptor to proliferative MAPK/NFκB/Akt signaling in neuroendocrine tumor cells.\",\n      \"evidence\": \"Reciprocal immunoprecipitation coupling assay plus siRNA knockdown with proliferation/apoptosis and pathway Western blots in KRJ-I cells\",\n      \"pmids\": [\"25701539\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line context\", \"Direct GTP-loading/effector activation by Gα15 not measured\", \"Receptor specificity beyond β1AR not mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a BTK-dependent route from Gα15 to the full MAPK cascade (ERK/JNK/p38) driving malignant behavior, addressing how Gα15 transmits signal to the kinase module.\",\n      \"evidence\": \"Co-immunoprecipitation, BTK knockdown with GNA15-overexpression rescue, and viability/migration/invasion assays in thyroid carcinoma cells\",\n      \"pmids\": [\"38333922\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Gα15–BTK binding (direct vs indirect) not resolved\", \"Single lab, single tumor type\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified CD312 as a GPCR that engages Gα15 at its transmembrane intracellular segment to drive leukemia proliferation, extending the receptor repertoire feeding into Gα15-MAPK signaling.\",\n      \"evidence\": \"Transmembrane interaction binding assay, BrdU proliferation, GNA15 knockdown in a co-culture system with MAPK Western blots\",\n      \"pmids\": [\"39656442\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the transmembrane interaction not defined\", \"Co-culture system may not reflect cell-autonomous signaling\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected Gα15 to metabolic reprogramming, showing it activates AMPK-driven fatty acid oxidation to confer drug resistance—revealing a non-MAPK output relevant to therapy.\",\n      \"evidence\": \"Metabolomics, p-AMPK/CPT1/CPT2/CD36 Western blots, FAO inhibition with etomoxir, and overexpression/knockdown functional assays in B-ALL cells\",\n      \"pmids\": [\"39812998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How GPCR/Gα15 signaling links mechanistically to AMPK activation unresolved\", \"FAO inhibition only partially reverses resistance, implying additional effectors\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placed GNA15 under miR-211-5p control as a node influencing pyroptosis, glycolysis, and tumor-microenvironment immune function in melanoma metastasis.\",\n      \"evidence\": \"miRNA target validation, gain/loss-of-function, glycolysis/pyroptosis assays, and exosome transfer in melanoma cell lines\",\n      \"pmids\": [\"36642112\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"GNA15-specific mechanism relies heavily on computational prediction with limited direct validation\", \"Causal chain from GNA15 to pyroptosis/glycolysis not dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how Gα15's promiscuous receptor coupling is mechanistically reconciled with both MAPK activation and AMPK-driven metabolic rewiring, and whether a single effector logic operates across hematopoietic and solid-tumor contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural or biochemical reconstitution of Gα15 effector selectivity\", \"Direct effector(s) bridging Gα15 to AMPK not identified\", \"In vivo physiological role beyond cancer models uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 4]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ADRB1\", \"BTK\", \"ADGRE5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}